{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:57:36Z","timestamp":1794887856128,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Estrogen is a potent vasodilator through activation of endothelial nitric oxide synthase (eNOS). Arginine and its homologue homoarginine are substrates for NOS, while asymmetric dimethylarginine (ADMA) is a NOS inhibitor. Healthy, never-pregnant women aged 18 to 40 years (n\u2009=\u2009158) were categorized according to use of hormonal contraception into non-users (n\u2009=\u200976), users of estrogen contraceptives (EC-users, n\u2009=\u200958) and users of progestins-only contraceptives (PC-users, n\u2009=\u200924). Plasma homoarginine, arginine, ADMA and SDMA concentrations were assayed using a LC-MS\/MS method. Compared to non-users, EC users had higher plasma homoarginine (median (interquartile range) 1.63 (1.24, 2.04) vs. 2.39 (2.05, 2.85) \u00b5mol\/L, p\u2009&lt;\u20090.001), lower arginine (80.8 (72.4, 94.3) vs. 72.1 (62.9, 85.1) \u00b5mol\/L, p\u2009=\u20090.008) and ADMA (0.52 (0.46, 0.59) vs. 0.48 (0.42, 0.54) \u00b5mol\/L, p\u2009=\u20090.003) concentrations. The lowest median plasma homoarginine concentration (1.34 (0.92, 1.75) \u00b5mol) was seen in PC-users. No differences were seen in SDMA concentrations according to use of hormonal contraception. In healthy, never-pregnant women aged 18 to 40 years, use of estrogen containing contraception was associated with significantly higher plasma concentrations of homoarginine and lower plasma concentrations of arginine and ADMA as compared to non-users, while the lowest plasma homoarginine concentrations were seen in progestin-only users. Whether the observed changes in relation to use of hormonal contraception have an impact on cardiovascular status, should be evaluated in an intervention study.<\/jats:p>","DOI":"10.1038\/s41598-018-30708-y","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T14:18:11Z","timestamp":1533824291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Homoarginine Concentrations According to Use of Hormonal Contraception"],"prefix":"10.1038","volume":"8","author":[{"given":"Thea","family":"Helm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Varsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Herland","family":"Fl\u00f8tre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnethe","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gard Frodahl Tveitev\u00e5g","family":"Svingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Magne","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Bj\u00f8rke-Monsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"30708_CR1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00726-015-2014-1","volume":"47","author":"A Khalil","year":"2015","unstructured":"Khalil, A. & Hardman, L. The role of arginine, homoarginine and nitric oxide in pregnancy. Amino acids 47, 1715\u20131727, https:\/\/doi.org\/10.1007\/s00726-015-2014-1 (2015).","journal-title":"Amino acids"},{"key":"30708_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fphys.2016.00215","volume":"7","author":"JK Limberg","year":"2016","unstructured":"Limberg, J. K. et al. Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives. Frontiers in physiology 7, 215, https:\/\/doi.org\/10.3389\/fphys.2016.00215 (2016).","journal-title":"Frontiers in physiology"},{"key":"30708_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1549-8719.2011.00094.x","volume":"18","author":"AK Thompson","year":"2011","unstructured":"Thompson, A. K., Przemska, A., Vasilopoulou, D., Newens, K. J. & Williams, C. M. Combined oral contraceptive pills containing desogestrel or drospirenone enhance large vessel and microvasculature vasodilation in healthy premenopausal women. Microcirculation (New York, N.Y.: 1994) 18, 339\u2013346, https:\/\/doi.org\/10.1111\/j.1549-8719.2011.00094.x (2011).","journal-title":"Microcirculation (New York, N.Y.: 1994)"},{"key":"30708_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1210\/er.2001-0045","volume":"23","author":"KL Chambliss","year":"2002","unstructured":"Chambliss, K. L. & Shaul, P. W. Estrogen modulation of endothelial nitric oxide synthase. Endocrine reviews 23, 665\u2013686, https:\/\/doi.org\/10.1210\/er.2001-0045 (2002).","journal-title":"Endocrine reviews"},{"key":"30708_CR5","doi-asserted-by":"crossref","unstructured":"Mendelsohn, M. E. Protective effects of estrogen on the cardiovascular system. The American journal of cardiology 89, 12E\u201317E; discussion 17E\u201318E (2002).","DOI":"10.1016\/S0002-9149(02)02405-0"},{"key":"30708_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-5793(91)81434-A","volume":"294","author":"M Hecker","year":"1991","unstructured":"Hecker, M., Walsh, D. T. & Vane, J. R. On the substrate specificity of nitric oxide synthase. FEBS letters 294, 221\u2013224 (1991).","journal-title":"FEBS letters"},{"key":"30708_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pharmthera.2007.03.002","volume":"114","author":"SM Bode-Boger","year":"2007","unstructured":"Bode-Boger, S. M., Scalera, F. & Ignarro, L. J. The l-arginine paradox: Importance of the l-arginine\/asymmetrical dimethylarginine ratio. Pharmacol Ther 114, 295\u2013306 (2007).","journal-title":"Pharmacol Ther"},{"key":"30708_CR8","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","volume":"33","author":"MO Gore","year":"2013","unstructured":"Gore, M. O. et al. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arteriosclerosis, thrombosis, and vascular biology 33, 2682\u20132688, https:\/\/doi.org\/10.1161\/ATVBAHA.113.301219 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"30708_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MCO.0000000000000123","volume":"18","author":"D Atzler","year":"2015","unstructured":"Atzler, D., Schwedhelm, E. & Choe, C. U. L-homoarginine and cardiovascular disease. Curr Opin Clin Nutr Metab Care 18, 83\u201388, https:\/\/doi.org\/10.1097\/MCO.0000000000000123 (2015).","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"30708_CR10","doi-asserted-by":"publisher","first-page":"e001833","DOI":"10.1161\/JAHA.115.001833","volume":"4","author":"P Willeit","year":"2015","unstructured":"Willeit, P. et al. Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. Journal of the American Heart Association 4, e001833, https:\/\/doi.org\/10.1161\/JAHA.115.001833 (2015).","journal-title":"Journal of the American Heart Association"},{"key":"30708_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-09-0658","volume":"162","author":"P Valtonen","year":"2010","unstructured":"Valtonen, P. et al. ADMA concentration changes across the menstrual cycle and during oral contraceptive use: the Cardiovascular Risk in Young Finns Study. Eur J Endocrinol 162, 259\u2013265, https:\/\/doi.org\/10.1530\/EJE-09-0658 (2010).","journal-title":"Eur J Endocrinol"},{"key":"30708_CR12","doi-asserted-by":"crossref","unstructured":"Valtonen, P. et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72, 1879\u20131884, doi:JST.JSTAGE\/circj\/CJ-08-0240 (2008).","DOI":"10.1253\/circj.CJ-08-0240"},{"key":"30708_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01274-6","volume":"7","author":"I Seppala","year":"2017","unstructured":"Seppala, I. et al. The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis. Sci Rep 7, 1130, https:\/\/doi.org\/10.1038\/s41598-017-01274-6 (2017).","journal-title":"Sci Rep"},{"key":"30708_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0002-9378(71)90788-5","volume":"111","author":"BW Somerville","year":"1971","unstructured":"Somerville, B. W. Daily variation in plasma levels of progesterone and estradiol throughout the menstrual cycle. American journal of obstetrics and gynecology 111, 419\u2013426 (1971).","journal-title":"American journal of obstetrics and gynecology"},{"key":"30708_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/TCRM.S2143","volume":"4","author":"KP Wright","year":"2008","unstructured":"Wright, K. P. & Johnson, J. V. Evaluation of extended and continuous use oral contraceptives. Therapeutics and clinical risk management 4, 905\u2013911 (2008).","journal-title":"Therapeutics and clinical risk management"},{"key":"30708_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","volume":"53","author":"CL Shufelt","year":"2009","unstructured":"Shufelt, C. L. & Bairey Merz, C. N. Contraceptive hormone use and cardiovascular disease. Journal of the American College of Cardiology 53, 221\u2013231, https:\/\/doi.org\/10.1016\/j.jacc.2008.09.042 (2009).","journal-title":"Journal of the American College of Cardiology"},{"key":"30708_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.rbmo.2016.07.010","volume":"33","author":"S D\u2019Arpe","year":"2016","unstructured":"D\u2019Arpe, S. et al. Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review. Reproductive biomedicine online 33, 436\u2013448, https:\/\/doi.org\/10.1016\/j.rbmo.2016.07.010 (2016).","journal-title":"Reproductive biomedicine online"},{"key":"30708_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","volume":"20","author":"IJ Duijkers","year":"2015","unstructured":"Duijkers, I. J., Heger-Mahn, D., Drouin, D. & Skouby, S. A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen. The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception 20, 419\u2013427, https:\/\/doi.org\/10.3109\/13625187.2015.1044082 (2015).","journal-title":"The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception"},{"key":"30708_CR19","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/humrep\/deh493","volume":"19","author":"IJ Duijkers","year":"2004","unstructured":"Duijkers, I. J., Klipping, C., Verhoeven, C. H. & Dieben, T. O. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Human reproduction 19, 2668\u20132673, https:\/\/doi.org\/10.1093\/humrep\/deh493 (2004).","journal-title":"Human reproduction"},{"key":"30708_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/0002-9378(72)90185-8","volume":"112","author":"D Tulchinsky","year":"1972","unstructured":"Tulchinsky, D., Hobel, C. J., Yeager, E. & Marshall, J. R. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 112, 1095\u20131100 (1972).","journal-title":"Am J Obstet Gynecol"},{"key":"30708_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1010946414017","volume":"221","author":"Y Zhu","year":"2001","unstructured":"Zhu, Y. & Evans, M. I. Estrogen modulates the expression of L-arginine:glycine amidinotransferase in chick liver. Molecular and cellular biochemistry 221, 139\u2013145 (2001).","journal-title":"Molecular and cellular biochemistry"},{"key":"30708_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1475-097X.2007.00784.x","volume":"28","author":"H Saarelainen","year":"2008","unstructured":"Saarelainen, H. et al. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation. Clinical physiology and functional imaging 28, 120\u2013124, https:\/\/doi.org\/10.1111\/j.1475-097X.2007.00784.x (2008).","journal-title":"Clinical physiology and functional imaging"},{"key":"30708_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1191\/1358863x06vm636oa","volume":"11","author":"D Cevik","year":"2006","unstructured":"Cevik, D., Unay, O., Durmusoglu, F., Yurdun, T. & Bilsel, A. S. Plasma markers of NO synthase activity in women after ovarian hyperstimulation: influence of estradiol on ADMA. Vascular medicine (London, England) 11, 7\u201312, https:\/\/doi.org\/10.1191\/1358863x06vm636oa (2006).","journal-title":"Vascular medicine (London, England)"},{"key":"30708_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2006.09.018","volume":"195","author":"MO Verhoeven","year":"2007","unstructured":"Verhoeven, M. O., Hemelaar, M., Teerlink, T., Kenemans, P. & van der Mooren, M. J. Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study. Atherosclerosis 195, 181\u2013188, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.09.018 (2007).","journal-title":"Atherosclerosis"},{"key":"30708_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0656-x","volume":"17","author":"D Tsikas","year":"2018","unstructured":"Tsikas, D., Bollenbach, A., Hanff, E. & Kayacelebi, A. A. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovascular diabetology 17, 1, https:\/\/doi.org\/10.1186\/s12933-017-0656-x (2018).","journal-title":"Cardiovascular diabetology"},{"key":"30708_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.7326\/0003-4819-135-11-200112040-00009","volume":"135","author":"H Kawano","year":"2001","unstructured":"Kawano, H. et al. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Annals of internal medicine 135, 977\u2013981 (2001).","journal-title":"Annals of internal medicine"},{"key":"30708_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.contraception.2008.07.025","volume":"79","author":"JR Meendering","year":"2009","unstructured":"Meendering, J. R., Torgrimson, B. N., Miller, N. P., Kaplan, P. F. & Minson, C. T. Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women. Contraception 79, 41\u201349, https:\/\/doi.org\/10.1016\/j.contraception.2008.07.025 (2009).","journal-title":"Contraception"},{"key":"30708_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00392-017-1172-4","volume":"107","author":"IE Emrich","year":"2018","unstructured":"Emrich, I. E. et al. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clinical research in cardiology: official journal of the German Cardiac Society 107, 201\u2013213, https:\/\/doi.org\/10.1007\/s00392-017-1172-4 (2018).","journal-title":"Clinical research in cardiology: official journal of the German Cardiac Society"},{"key":"30708_CR29","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1253\/circj.CJ-14-0484","volume":"78","author":"D Tsikas","year":"2014","unstructured":"Tsikas, D. & Kayacelebi, A. A. Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system? Circ J 78, 2094\u20132095, https:\/\/doi.org\/10.1253\/circj.CJ-14-0484 (2014).","journal-title":"Circ J"},{"key":"30708_CR30","doi-asserted-by":"publisher","first-page":"10453","DOI":"10.1021\/bi980742t","volume":"37","author":"C Moali","year":"1998","unstructured":"Moali, C., Boucher, J. L., Sari, M. A., Stuehr, D. J. & Mansuy, D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 37, 10453\u201310460, https:\/\/doi.org\/10.1021\/bi980742t (1998).","journal-title":"Biochemistry"},{"key":"30708_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.109.908988","volume":"122","author":"W Marz","year":"2010","unstructured":"Marz, W. et al. Homoarginine, cardiovascular risk, and mortality. Circulation 122, 967\u2013975, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.908988 (2010).","journal-title":"Circulation"},{"key":"30708_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/cvr\/cvw062","volume":"110","author":"I Alesutan","year":"2016","unstructured":"Alesutan, I. et al. Augmentation of phosphate-induced osteo-\/chondrogenic transformation of vascular smooth muscle cells by homoarginine. Cardiovascular research 110, 408\u2013418, https:\/\/doi.org\/10.1093\/cvr\/cvw062 (2016).","journal-title":"Cardiovascular research"},{"key":"30708_CR33","doi-asserted-by":"publisher","first-page":"46789","DOI":"10.1074\/jbc.M306787200","volume":"278","author":"LE Bretscher","year":"2003","unstructured":"Bretscher, L. E., Li, H., Poulos, T. L. & Griffith, O. W. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. The Journal of biological chemistry 278, 46789\u201346797, https:\/\/doi.org\/10.1074\/jbc.M306787200 (2003).","journal-title":"The Journal of biological chemistry"},{"key":"30708_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1476-5381.1992.tb09053.x","volume":"105","author":"RG Bogle","year":"1992","unstructured":"Bogle, R. G., Moncada, S., Pearson, J. D. & Mann, G. E. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. British journal of pharmacology 105, 768\u2013770 (1992).","journal-title":"British journal of pharmacology"},{"key":"30708_CR35","doi-asserted-by":"publisher","unstructured":"Chafai, A., Fromm, M. F., Konig, J. & Maas, R. The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B. Scientific reports 7, 4767, https:\/\/doi.org\/10.1038\/s41598-017-04965-2 (2017).","DOI":"10.1038\/s41598-017-04965-2"},{"key":"30708_CR36","doi-asserted-by":"publisher","unstructured":"Wu, G., Bazer, F. W., Hu, J., Johnson, G. A. & Spencer, T. E. Polyamine synthesis from proline in the developing porcine placenta. Biology of reproduction 72, 842\u2013850, https:\/\/doi.org\/10.1095\/biolreprod.104.036293 (2005).","DOI":"10.1095\/biolreprod.104.036293"},{"key":"30708_CR37","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1073\/pnas.1219002110","volume":"110","author":"S Mandal","year":"2013","unstructured":"Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V. & Park, M. H. Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc Natl Acad Sci USA 110, 2169\u20132174, https:\/\/doi.org\/10.1073\/pnas.1219002110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30708_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4939-2480-6_2","volume":"843","author":"FW Bazer","year":"2015","unstructured":"Bazer, F. W., Johnson, G. A. & Wu, G. Amino acids and conceptus development during the peri-implantation period of pregnancy. Adv Exp Med Biol 843, 23\u201352, https:\/\/doi.org\/10.1007\/978-1-4939-2480-6_2 (2015).","journal-title":"Adv Exp Med Biol"},{"key":"30708_CR39","doi-asserted-by":"crossref","unstructured":"Bjorke-Jenssen, A., Ueland, P. M. & Bjorke-Monsen, A. L. Amniotic Fluid Arginine from Gestational Weeks 13 to 15 Is a Predictor of Birth Weight, Length, and Head Circumference. Nutrients 9, doi:10.3390\/nu9121357 (2017).","DOI":"10.3390\/nu9121357"},{"key":"30708_CR40","doi-asserted-by":"crossref","unstructured":"Kim, S. Overview of Cotinine Cutoff Values for Smoking Status Classification. International journal of environmental research and public health 13, doi:10.3390\/ijerph13121236 (2016).","DOI":"10.3390\/ijerph13121236"},{"key":"30708_CR41","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00216-012-6602-6","volume":"405","author":"O Midttun","year":"2013","unstructured":"Midttun, O., Kvalheim, G. & Ueland, P. M. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS\/MS. Analytical and bioanalytical chemistry 405, 2009\u20132017, https:\/\/doi.org\/10.1007\/s00216-012-6602-6 (2013).","journal-title":"Analytical and bioanalytical chemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30708-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:35:46Z","timestamp":1671611746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30708"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30708-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12217"}}